stars 1 stars 2 stars 3

Curapath, is a global CDMO specialized in the tailored design, development, and GMP manufacturing of cutting-edge polymer and lipid-based drug delivery systems. Our customers benefit from our unique expertise, operational excellence and technical solutions in polymer nanoparticles (PNPs) and lipid nanoparticles (LNPs) along with their essential components. In addition, we have extensive experience in drug conjugation and cross-linking, to increase stability, reduce toxicity, and enhance bioactivity. At Curapath, we stand as your partner from discovery stages to commercial GMP scale-up. With our dedicated support, expertise, and state of the art manufacturing capabilities, we assure you a guaranteed path for your drug to navigate through clinical development and reach commercialization seamlessly Your success is our commitment

Curapath Questions

The Curapath annual revenue was $2.6 million in 2026.

Philippe Clavel is the CEO of Curapath.

71 people are employed at Curapath.

Curapath is based in Valencia, Valencia.

Top Curapath Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users